Drug Trial Radar · NCT07192952
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
117
Planned (sponsor's estimate)
Start
Jun 1, 2026
Primary completion
Dec 30, 2030
Study completion Dec 30, 2030
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Sep 25, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Researchers are looking for a better way to treat children and young adults who have heart failure with left ventricular systolic dysfunction (LVSD). Heart failure with left ventricular systolic dysfunction (LVSD) is a condition where the left side of the heart is weak and struggles to pump blood effectively, leading to symptoms like shortness of breath, fatigue, and poor growth. The study treatment, finerenone (also called BAY94-8862), is under development to treat newborns, children, and young adults with heart failure and LVSD. It works by blocking a protein that contributes to inflammation, scarring, and thickening in the heart and blood vessels, which may help the heart pump more blood effectively. The main purpose of this study is to learn about how safe finerenone is and how well it works in the long-term treatment of heart failure and LVSD. To understand how safe the treatment is, the study team will gather information on the number of patients who experience medical problems after taking finerenone, also known as "treatment emergent adverse events" (TEAEs). Additionally, they will collect blood samples to measure levels of an electrolyte called potassium and monitor blood pressure. They will also assess kidneys function using the estimated glomerular filtration rate (eGFR). In this study, which is an extension of the earlier done FIORE study, finerenone will also be studied in newly enrolled newborns under 6 months with heart failure and LVSD and children and young adults from the FIORE study. The participants will be aged from newborns up to 18 years. All the participants will continue to receive their standard treatment as routine care for heart failure, along with finerenone during the study. The participants will be in the study for around 10 to 11 months, depending on whether they rolled-over from the FIORE study or are newly enrolled newborns and infants \<6 months of age. They will take study treatment for up to 9 months. During this period, at least 6 visits are planned for participants. During these visits, the study team will: * have their blood pressure, heart rate, temperature, respiratory rate, height and weight measured * have blood samples taken * have physical examinations * have their heart examined by an electrocardiogram and echocardiography * answer questions about their medication and whether they have any adverse events, or have their parents or guardians' answer * for newborns and infants, evaluate the acceptability of the study drug formulation through parents or guardians' feedback. An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events that happen in studies, even if they do not think the adverse events might be related to the study treatments. The doctors will check the participants' health a month after the participants take their last treatment.
Conditions
- Left Ventricular Systolic Dysfunction
- Heart Failure (Pediatric)
Interventions
Finerenone (Kerendia, BAY94-8862)Drug
Finerenone in different doses, treatment duration will be 270±7 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with treatment-emergent adverse events (TEAEs)Time frame: From the start of study intervention to last study intervention (up to 277 days) + 3 days
- Change in serum potassium levelsTime frame: From baseline to Day 270±7
- Change in systolic blood pressure (SBP)Time frame: From baseline to Day 270±7
- Change in estimated glomerular filtration rate (eGFR)Time frame: From baseline to Day 270±7
Locations
132 sites in 23 countries. Site status is shown where the registry gives one.
Children's Hospital Colorado - Anschutz Medical Campus - Cardiology
Aurora, Colorado · Not yet recruiting
Nemours Children's Hospital - Delaware - Cardiology
Wilmington, Delaware · Not yet recruiting
UF Health Shands Hospital - Pediatric Cardiology
Gainesville, Florida · Not yet recruiting
Joe Dimaggio Children's Hospital - Cardiology
Hollywood, Florida · Not yet recruiting
Emory University Hospital - Children's Healthcare of Atlanta Cardiology - Atlanta
Atlanta, Georgia · Not yet recruiting
Riley Hospital For Children - Cardiology
Indianapolis, Indiana · Not yet recruiting
Boston Children's Hospital - Main Campus - Cardiology
Boston, Massachusetts · Not yet recruiting
C.S. Mott Children's Hospital - Cardiology
Ann Arbor, Michigan · Not yet recruiting
Children's Mercy Hospital Kansas City - Cardiology
Kansas City, Missouri · Not yet recruiting
Washington University - St. Louis Children's Hospital - Cardiology
St Louis, Missouri · Not yet recruiting
Icahn School of Medicine at Mount Sinai - Pediatric Cardiology
New York, New York · Not yet recruiting
Columbia University Irving Medical Center - Pediatric Cardiology
New York, New York · Not yet recruiting
The Children's Hospital at Montefiore - Cardiology
The Bronx, New York · Not yet recruiting
Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension
Cincinnati, Ohio · Not yet recruiting
Cleveland Clinic Children's
Cleveland, Ohio · Not yet recruiting
Nationwide Children's Hospital - Cardiology
Columbus, Ohio · Not yet recruiting
Children's Hospital of Philadelphia - Cardiology
Philadelphia, Pennsylvania · Not yet recruiting
UPMC Children's Hospital of Pittsburgh - Cardiology
Pittsburgh, Pennsylvania · Not yet recruiting
MUSC Shawn Jenkins Children's Hospital - Cardiology
North Charleston, South Carolina · Not yet recruiting
Children's Medical Center Dallas - Cardiology
Dallas, Texas · Not yet recruiting
Texas Children's Hospital - Cardiology
Houston, Texas · Not yet recruiting
Eccles Primary Children's Outpatient Services - Cardiology
Salt Lake City, Utah · Not yet recruiting
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina · Not yet recruiting
Hospital de Pediatría Juan P. Garrahan
Buenos Aires, Argentina · Not yet recruiting
Hospital General de Ninos Pedro de Elizalde | Nephrology Department
Buenos Aires, Argentina · Not yet recruiting
Consultorios Médicos Dr. Doreski
Buenos Aires, Argentina · Not yet recruiting
Sanatorio de la Cañada
Córdoba, Argentina · Not yet recruiting
Centro Cardiovascular Salta (Torzav SRL)
Salta, Argentina · Not yet recruiting
Hospital de Niños Sor María Ludovica
La Plata, Buenos Aires, Argentina · Not yet recruiting
Instituto De Investigaciones Clinicas Zarate | Zarate, Argentina
Zárate, Buenos Aires, Argentina · Not yet recruiting
Hospital General de Ninos Ricardo Gutierrez | Cardiology Department
Buenos Aires, Ciudad Autónoma de Buenos Aires (caba), Argentina · Not yet recruiting
Consultorios Integrados Rosario | Instituto Medico de la Fundacion de Estudios Clinicos
Rosario, Santa Fe Province, Argentina · Not yet recruiting
Medizinische Universität Wien - Klinik für Kinder- und Jugendheilkunde, Abteilung für Pädiatrische Kardiologie
Vienna, State of Vienna, Austria · Not yet recruiting
Kepler Universitätsklinikum GmbH - Klinik für Kinderkardiologie
Linz, Upper Austria, Austria · Not yet recruiting
CHC MontLegia - Pediatric Cardiology
Liège, Belgium · Not yet recruiting
UZ Antwerpen - Pediatric Cardiology
Edegem, Antwerp, Belgium · Not yet recruiting
Cliniques Universitaires St-Luc (UCL) - Pediatric Cardiology
Brussels, Brussels Capital, Belgium · Recruiting
UZ Gent - Pediatric Cardiology
Ghent, East Flanders, Belgium · Not yet recruiting
UZ Leuven - Pediatric Cardiology
Leuven, Flemish Brabant, Belgium · Not yet recruiting
Hospital Infantil Sabará - Instituto PENSI - Pesquisa e Ensino em Saúde Infantil
São Paulo, Brazil · Not yet recruiting
Showing 40 of 132 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.